Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature

Cancer Research

Volumn 57, Issue 10, 1997, Pages 1829-1834

  Dark, Graham G ^a   Hill, Sally A ^a   Prise, Vivien E ^a   Tozer, Gillian M ^a   Pettit, George R ^b   Chaplin, Dai J ^a  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

^b ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; COMBRETASTATIN A4;

ANGIOGENESIS; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BLEEDING; BLOOD VESSEL INJURY; BREAST CANCER; CANCER ADJUVANT THERAPY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MECHANISM; ENDOTHELIUM CELL; HISTOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; NECROSIS; NONHUMAN; PRIORITY JOURNAL; TUMOR BLOOD FLOW; VASCULAR ENDOTHELIUM;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; ENDOTHELIUM, VASCULAR; HINDLIMB; HUMANS; MICE; MICE, INBRED CBA; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; PERFUSION; PRODRUGS; RATS; STILBENES;

EID: 0030951899     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Fan, T. P., Jaggar, R., and Bicknell, R. Controlling the vasculature: angiogenesis, anti-angiogenesis and vascular targeting of gene therapy. Trends Pharmacol. Sci., 16: 57-66, 1995.
2. Yamamoto, T., Sudo, K., and Fujita, T. Significant inhibition of endothelial cell growth in tumor vasculature by an angiogenesis inhibitor, TNP-470 (AGM-1470). Anticancer Res., 14: 1-3, 1994.
3. Wellstein, A., Zugmaier, G., Califano, J. A. d., Kern, F., Paik, S., and Lippman, M. E. Tumor growth dependent on Kaposi's sarcoma-derived fibroblast growth factor inhibited by pentosan polysulfate. J. Natl. Cancer Inst., 83: 716-720, 1991.
4. Vukanovic, J., Passaniti, A., Hirata, T., Traystman, R. J., Hartley Asp, B., and Isaacs, J. T. Antiangiogenic effects of the quinoline-3-carboxamide linomide. Cancer Res., 53: 1833-1837, 1993.
5. D'Amato, R. J., Loughnan, M. S., Flynn, E., and Folkman, J. Thalidomide is an inhibitor of angiogenesis. Proc. Natl. Acad. Sci. USA, 91: 4082-4085, 1994.
6. Fotsis, T., Zhang, Y., Pepper, M. S., Adlercreutz, H., Montesano, R., Nawroth, P. P., and Schweigerer, L. The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature (Lond.), 368: 237-239, 1994.
7. Strawn, L. M., McMahon G., App, H., Schreck, R., Huchler, W. R., Longhi, M. P., Hui, T. H., Tang, C., Levitzki, A., Gazit, A., Chen, I., Keri, G., Orfi, L., Risau, W., Flamme I., Ullrich, A., Hirth, K. P., and Shawver, L. K. Flk-1 as a target for tumour growth inhibition. Cancer Res., 56: 3540-3545, 1996.
8. Chaplin, D. J., Pettit, G. R., Parkins, C. S., and Hill, S. A. Antivascular approaches to solid tumour therapy: evaluation of tubulin binding agents. Br. J. Cancer, 74: S86-S88, 1996.
9. Hill, S. A., Lonergan, S. J., Denekamp, J., and Chaplin, D. J. Vinca alkaloids: anti-vascular effects in a murine tumour. Eur. J. Cancer, 29A: 1320-1324, 1993.
10. Hill, S. A. Sampson, L. E., and Chaplin, D. J. Anti-vascular approaches to solid tumour therapy: evaluation of vinblastine and flavone acetic acid. Int. J. Cancer, 63: 119-123, 1995.
11. Hill, S., Williams, K. B., and Denekamp, J. Vascular collapse after flavone acetic acid: a possible mechanism of its anti-tumour action. Eur. J. Cancer Clin. Oncol., 25: 1419-1424, 1989.
12. Bibby, M. C., Double, J. A., Loadman, P. M., and Duke, C. V. Reduction of tumor blood flow by flavone acetic acid: a possible component of therapy. J. Natl. Cancer Inst., 81: 216-220, 1989.
13. Zwi, L. J., Baguley, B. C., Gavin, J. B., and Wilson, W. R. Blood flow failure as a major determinant in the antitumor action of flavone acetic acid. J. Natl. Cancer Inst., 81: 1005-1013, 1989.
14. Ludford, R. J. The action of toxic substances upon the division of normal and malignant cells in vitro and in vivo. Arch. Exp. Zellforsch., 18: 411-441, 1936.
15. Ludford, R. J. Colchicine in the experimental chemotherapy of cancer. J. Natl. Cancer Inst., 6: 89-101, 1945.
16. Pettit, G. R., Singh, S. B., Hamel, E., Lin, C. M., Alberts, D. S. and Garcia-Kendall, D. Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4. Experientia, 45: 209-211, 1989.
17. Vaupel, P. Oxygenation of human tumors. Strahlenther. Onkol., 166: 377-386, 1990.
18. Chaplin, D. J., and Hill, S. A. Temporal heterogeneity in microregional erythrocyte flux in experimental solid tumours. Br. J. Cancer, 71: 1210-1213, 1995.
19. Mueller Klieser, W., Vaupel, P., Manz, R., and Schmidseder, R. Intracapillary oxyhemoglobin saturation of malignant tumors in humans. Int. J. Radiat. Oncol. Biol. Phys., 7: 1397-1404, 1981.
20. Watts, M. E., and Woodcock, M. Flavone acetic acid induced changes in human endothelial permeability: potentiation by tumour-conditioned medium. Eur. J. Cancer, 28A: 1628-1632, 1992.
21. Jaffe, E. A., Nachman, R. L., Becker, C. G., and Minick, C.R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest., 52: 2745-2756, 1973.
22. Pettit, G. R., Temple, C., Jr., Narayanan, V. L., Varma, R., Simpson, M. J., Boyd, M. R., Rener, G. A., and Bansal, N. Antineoplastic agents 322. Synthesis of combretastatin A-4 prodrugs. Anticancer Drug Des., 10: 299-309, 1995.
23. Tozer, G. M., Prise, V. E., and Bell, K. M. The influence of nitric oxide on tumour vascular tone. Acta Oncol., 34: 373-377, 1995.
24. Borenfreund, E., Babich, H., and Martin-Alguacil, N. Rapid chemosensitivity assay with human normal and tumor cells in vitro. In Vitro Cell Dev. Biol., 26: 1030-1034, 1990.
25. Burtles, S. S., Newell, D. R., Henrar, R. E., and Connors, T. A. Revisions of general guidelines for the preclinical toxicology of new cytotoxic anticancer agents in Europe. The Cancer Research Campaign (CRC) Phase I/II Clinical Trials Committee and the European Organization for Research and Treatment of Cancer (EORTC) New Drug Development Office. Eur. J. Cancer, 31A: 408-410, 1995.
26. Tozer, G. M., Shaffi, K. M., Prise, V. E., and Cunningham, V. J. Characterisation of tumour blood flow using a "tissue-isolated" preparation. Br. J. Cancer, 70: 1040-1046, 1994.
27. Smith, K. A., Hill, S. A., Begg, A. C., and Denekamp, J. Validation of the fluorescent dye Hoechst 33342 as a vascular space marker in tumours. Br. J. Cancer, 57: 247-253, 1988.
28. Chalkley H. W. Method for the quantitative morphologic analysis of tissues. J. Natl. Cancer Inst., 4: 47, 1943.
29. Burrows, F. J., and Thorpe, P. E. Eradication of large solid tumors in mice with an immunotoxin directed against tumor vasculature. Proc. Natl. Acad. Sci. USA, 90: 8996-9000, 1993.
30. Brooks, P. C., Montgomery, A. M., Rosenfeld, M. Reisfeld, R. A., Hu, T., Klier, G., and Cheresh, D. A. Integrin α v β 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell, 79: 1157-1164, 1994.
31. Ozaki, K., Yoshida, T., Ide, H., Saito, I., Ikeda, Y., Sugimura, T., and Terade, M. Use of von Willebrand factor promoter to transduce suicidal gene to human endothelial cell, HUVEC. Hum. Gene Ther., 7: 1483-1490, 1996.
32. Baguley, B. C., Holdaway, K. H., Thomsen, L. L., Zhuang, L., and Zwi, L. J. Inhibition of growth of colon 38 adenocarcinoma by vinblastine and colchicine: evidence for a vascular mechanism. Eur. J. Cancer, 27: 482-487, 1991.
33. Avila, J. Microtubule functions. Life Sci., 50: 327-334, 1992.
34. Hill, S. A., Williams, K. B., and Denekamp, J. Studies with a panel of tumours, having a variable sensitivity to FAA, to investigate its mechanism of action. Int. J. Radiat. Biol., 60: 379-384, 1991.
35. Ching, L. M., Joseph, W. R., Crosier, K. E., and Baguley, B. C. Induction of tumor necrosis factor-α messenger RNA in human and murine cells by the flavone acetic acid analogue 5,6-dimethylxanthenone-4-acetic acid (NSC 640488). Cancer Res., 54: 870-872, 1994.
36. Tablin F., Castro M., and Leven, R. M. Blood platelet formation in vitro. The role of the cytoskeleton in megakaryocyte fragmentation. J. Cell Sci., 97: 59-70, 1990.